Details for Patent: 5,164,190
✉ Email this page to a colleague
Summary for Patent: 5,164,190
Title: | Subsaturated transdermal drug delivery device exhibiting enhanced drug flux |
Abstract: | Transdermal administration of hydrophobic drugs via a diffusion mechanism in which the drug is dissolved in a carrier at concentrations that are 20% to 80% of the saturation concentration. The flux of drug from the device is non-Fickian and is substantially greater than the flux observed when the drug is at saturation. |
Inventor(s): | Patel; Dinesh C. (Murray, UT), Ebert; Charles D. (Salt Lake City, UT) |
Assignee: | Theratech, Inc. (Salt Lake City, UT) |
Application Number: | 07/626,685 |
Patent Claim Types: see list of patent claims | Compound; Device; Composition; Delivery; Use; |
Drugs Protected by US Patent 5,164,190
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,164,190
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 225166 | ⤷ Try a Trial | |||
Australia | 651165 | ⤷ Try a Trial | |||
Australia | 9175791 | ⤷ Try a Trial | |||
Canada | 2098195 | ⤷ Try a Trial | |||
Germany | 69133123 | ⤷ Try a Trial | |||
Denmark | 0562041 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |